https://caselaw.findlaw.com/summary/opinion/us-federal-circuit/2018/09/10/284235.html
Content Reproduced verbatim from the Website of FindLaw, A Thomson Reuters Business, as permitted under their RSS FEEDS, Terms of Use.
Orexo AB v. Actavis Elizabeth LLC, 17-1333
Reversed a judgment that a patent for a pharmaceutical product was invalid on the ground of obviousness. The Federal Circuit concluded that obviousness was not proved by clear and convincing evidence.
Appellate Information
- Decided
- Published 2018/09/10
Judges
Court
- United States Federal Circuit